Are inflammation and ossification on separate tracks in ankylosing spondylitis?
Claudepierre
Pascal
P
Wendling
Daniel
D
D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use; D004195:Disease Models, Animal; D000068800:Etanercept; D006168:Guinea Pigs; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D051379:Mice; D009999:Ossification, Heterotopic / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept